ProFunds Pharmaceuticals UltraSector Fund

Scorecard
2 / 5 Stars
Lipper
3 3 3 2 2
Zacks Investment Research
2 (Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A+ (Buy)